Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients

International Journal of Laboratory Hematology

Volumn 32, Issue 4, 2010, Pages 387-391

  Ballestrero, A ^a   Cirmena, G ^a   Dominietto, A ^b   Garuti, A ^a   Rocco, I ^a   Cea, M ^a   Moran, E ^a   Nencioni, A ^a   Miglino, M ^a   Raiola, A M ^b   Bacigalupo, A ^b   Patrone, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Allogeneic stem cell transplantation; Bone marrow; Chronic myeloid leukemia; Peripheral blood; RQ PCR

Indexed keywords

BCR ABL PROTEIN;

ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW; CHILD; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ADOLESCENT; ADULT; BONE MARROW; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77957946403     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01198.x     Document Type: Article

References (13)

1. Baccarani M., Martinelli G., Rosti G., Trabacchi E., Testoni N., Bassi S., Amabile M., Soverini S., Castagnetti F., Cilloni D., Izzo B., de Vivo A., Messa E., Bonifazi F., Poerio A., Luatti S., Giugliano E., Alberti D., Fincato G., Russo D., Pane F. & Saglio G.; GIMEMA Working Party on Chronic Myeloid Leukemia. (2004) Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia. Blood 104, 4245-4251.
2. Baccarani M., Saglio G., Goldman J., Hochhaus A., Simonsson B., Appelbaum F., Apperley J., Cervantes F., Cortes J., Deininger M., Gratwohl A., Guilhot F., Horowitz M., Hughes T., Kantarjian H., Larson R., Niederwieser D., Silver R. & Hehlmann R. (2006) Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European Leukemia Net. Blood 108, 1809-1820.
3. Branford S., Fletcher L., Cross N. C., Müller M. C., Hochhaus A., Kim D. W., Radich J. P., Saglio G., Pane F., Kamel-Reid S., Wang Y. L., Press R. D., Lynch K., Rudzki Z., Goldman J. M. & Hughes T. (2008) Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood 112, 3330-3338.
4. Cortes J., Talpaz M., O'Brien S., Jones D., Luthra R., Shan J., Giles F., Faderl S., Verstovsek S., Garcia-Manero G., Rios M. B. & Kantarjian H. (2005) Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate. Clinical Cancer Research 11, 3425-3432. (Pubitemid 40627896)
5. Cross N. C. P., Lin F., Chase A., Bungey J., Hughes T. P. & Goldman J. M. (1993) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82, 1929-1936.
6. Gabert J., Beillard E., van der Velden V. H. J., Bi W., Grimwade D., Pallisgaard N., Barbany G., Cazzaniga G., Cayuela J. M., Cavé H., Pane F., Aerts J. L., De Micheli D., Thirion X., Pradel V., González M., Viehmann S., Malec M., Saglio G. & van Dongen J. J. (2003) Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe against Cancer Program. Leukemia 17, 2318-2357.
7. Kaeda J., O'Shea D., Szydlo R. M., Olavarria E., Dazzi F., Marin D., Saunders S., Khorashad J. S., Cross N. C., Goldman J. M. & Apperley J. F. (2006) Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy. Blood 107, 4171-4176.
8. Olavarria E., Kanfer E., Szydlo R., Kaeda J., Rezvani K., Cwynarski K., Pocock C., Dazzi F., Craddock C., Apperley J. F., Cross N. C. & Goldman J. M. (2001) Early detection of BCR-ABL transcripts by quantitative RT-PCR predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 97, 1560-1565.
9. Ou J., Vergilio J. A. & Bagg A. (2008) Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukaemia treated with tyrosine kinase inhibitors. American Journal of Hematology 83, 296-302.
10. Palandri F., Iacobucci I., Martinelli G., Amabile M., Poerio A., Testoni N., Soverini S., Castagnetti F., De Vivo A., Breccia M., Specchia G., Abruzzese E., Martino B., Cilloni D., Saglio G., Pane F., Liberati A. M., Rosti G. & Baccarani M.; GIMEMA Working Party on CML. (2008) Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, Philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. Journal of Clinical Oncology 26, 106-111.
11. Paschka P., Muller M. C., Merx K., Kreil S., Schoch C., Lahaye T., Weisser A., Petzod A., Konig H., Berger U., Gschaidmeier H., Hehlmann R. & Hochhaus A. (2003) Molecular monitoring of response to imatinib (Glivec) in CML patients pre-treated with interferon alpha low levels of residual disease are associated with continuous remission. Leukemia 17, 1687-1694.
12. Radich J. P., Gehly G., Gooley T., Bryant E., Clift R. A., Collins S., Edmands S., Kirk J., Lee A. & Kessler P. (1995) Polymerase chain reaction detection of Bcr-Abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 85, 2632-2638.
13. Stock W., Yu D., Karrison T., Sher D., Stone R. M., Larson R. A. & Bloomfield C. D. (2006) Quantitative real time PCR monitoring of BCR-ABL in CML shows lack of agreement in blood and bone marrow samples. Cancer and Leukemia Group B Study 29801. International Journal of Oncology 28, 1099-1103.